Clinical Trials Browser

Phase 2 × Unknown × Plasmacytoma × Clear all

NCT04162119 2019-11-18

Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Phase 2 Unknown

Multiple Myeloma, Plasmacytoma, Neoplasms, Plasma Cell

NCT04065308 2019-08-22

Dara_DCEP

Phase 2 Unknown

Plasmacytoma